Frank Vinluan is senior biopharma reporter for MedCity News. Prior to this he was a senior editor at Xconomy where he wrote and edited stories about a wide range of topics including cancer immunotherapy, cell and gene therapies, gene editing technologies, and rare disease drugs. Before moving into biotech journalism, Frank held business reporting positions at The Des Moines Register and The Seattle Times. He wrote his first clinical trials story as a staff reporter at the Triangle Business Journal.
